The peptides under consideration this week are: BPC-157, proposed for treating ulcerative colitis KPV for wound healing and inflammatory conditions TB-500 for wound healing MOTs-C for obesity and osteoporosis Emideltide for opioid withdrawal, chronic insomnia and narcolepsy Semax for certain neurological disorders Epitalon for insomnia The FDA advisory committee will be determining whether or not it will allow access to these substances through legitimate state-licensed compounding pharmacies, said Scott Brunner, chief executive officer of the Alliance for Pharmacy Compounding, who sent a public letter to the committee in support of adding peptides to the list
Calculate the required volume of reconstitution solution based on your peptides mass and desired final concentration
Many first-time skincare founders do not have a technical background in formulation, packaging, or regulatory compliance
Kim K, et al
Clinical Research Insights
Pittsburgh: What to See, Do, and Eat I recently traveled to Pittsburgh for a work conference, and you can bet I made time for some sightseeing
